Babajide Sanwo-Olu, the Lagos State Governor has given approval for the clinical trial of Ivermectin drug for the prevention and treatment of COVID-19 infection in the state.
The Governor in a statement on Sunday noted that while the drug will not be deployed yet for general use, the clinical trial approval was given based on international reviews of its efficacy.
He said, “The State Government is aware of numerous international claims that the broad spectrum anti-parasitic agent/medication Ivermectin has shown some efficacy in acting as a sustained prophylaxis in containing/inhibiting the causative virus in SARS CoV-2.
“While this medication has not yet been approved for the broad treatment of the Coronavirus disease, the State Government has however taken the bold step of ensuring we have adequate stocks of Ivermectin, which will be initially deployed in a short clinical trial to ascertain its efficiency in our population to prevent and treat COVID-19 infection.”
Sanwo-Olu added that his administration will not relax in making oxygen available free of charge to patients that may need it, noting that the state was on the verge of delivering its second oxygen plant at the Gbagada General Hospital.
“The Government will keep the integrity of the vaccines intact along the entire supply and distribution chain, while also ensuring approved dosages are complied with.
“The state will follow up on possible post-vaccination adverse event; the monitoring strategy will be diligently followed in line with protocols of pharmaceutical public safety,” he added.